Related Experiment Video
Updated: Dec 14, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
The Circumferential Resection Margin Is a Prognostic Predictor in Colon Cancer
Xin-Yi Tang1,2, Meng-Xi Huang1, Si-Qi Han1
1Department of Medical Oncology, School of Medicine, Jingling Hospital, Nanjing University, Nanjing, China.
Circumferential resection margin (CRM) positivity is a poor prognostic indicator in colon cancer. Achieving a CRM greater than 30 mm improves patient outcomes, with chemotherapy offering significant survival benefits.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Prognostics
Background:
- Circumferential resection margin (CRM) is a critical prognostic factor in rectal and esophageal cancers.
- Its prognostic value in colon cancer remains less understood.
- This study addresses the significance of CRM in colon cancer prognostication.
Purpose of the Study:
- To evaluate the prognostic value of CRM in colon cancer.
- To identify optimal CRM cutoff values for predicting survival.
- To assess the impact of CRM on overall survival and response to chemotherapy.
Main Methods:
- Utilized data from 6,681 CRM-positive and 25,908 CRM-negative colon cancer patients (2010-2015) from the SEER database.
- Employed statistical analyses including chi-square, Kaplan-Meier, Cox proportional hazards models, and X-tile software.
- Propensity score matching was performed to control for confounding factors.
Main Results:
- CRM positivity was significantly associated with poorer survival (P < 0.001).
- Optimal cutoff values of 0 mm and 30 mm for CRM were identified for stages II-IV.
- Patients with CRM > 30 mm had a 33% reduced risk of mortality; chemotherapy improved overall survival, particularly for those with CRM 0-30 mm.
Conclusions:
- CRM positivity is a strong negative prognostic indicator in colon cancer.
- A CRM of > 30 mm is associated with improved outcomes for stages II-IV.
- Number of regional lymph nodes is a valuable substitute for CRM in stage I, and chemotherapy benefits overall survival.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
04:45Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021